Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
DMK PHARMACEUTICALS Corp | CEO, Director | Common Stock | 906K | $547K | $0.60 | Sep 15, 2023 | By Versi Group LLC |
DMK PHARMACEUTICALS Corp | CEO, Director | Common Stock | 8.75K | $5.28K | $0.60 | Sep 15, 2023 | Direct |
DMK PHARMACEUTICALS Corp | CEO, Director | Series E Convertible Preferred Stock | 1.21K | Sep 15, 2023 | By Versi Group LLC |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADMP | DMK PHARMACEUTICALS Corp | Sep 15, 2023 | 2 | $0 | 4 | Sep 19, 2023 | CEO, Director |
ADMP | Adamis Pharmaceuticals Corp | May 25, 2023 | 8 | $0 | 4 | May 30, 2023 | CEO, Director |
ADMP | Adamis Pharmaceuticals Corp | May 25, 2023 | 0 | $0 | 3 | May 30, 2023 | CEO, Director |